Indication
Chronic pulmonary histoplasmosis
Chronic pulmonary histoplasmosis is a persistent, progressive fungal infection of the respiratory system caused by the inhalation of *Histoplasma capsulatum* spores. Read more about Chronic pulmonary histoplasmosis
1 drugs 1 manufacturers
Drugs that treat it
Common Chronic pulmonary histoplasmosis therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonChronic pulmonary histoplasmosis is a persistent, progressive fungal infection of the respiratory system caused by the inhalation of *Histoplasma capsulatum* spores.
This clinical entity predominantly affects older adults and individuals with pre-existing structural lung diseases, particularly emphysema or chronic obstructive pulmonary disease.
Pathophysiologically, the organism colonizes abnormal lung spaces, prompting sustained necrotizing inflammation, pulmonary fibrosis, and progressive apical or upper-lobe cavitation that closely mimics pulmonary tuberculosis.
Clinically, affected patients experience an insidious, prolonged illness characterized by chronic productive cough, hemoptysis, dyspnea, low-grade fevers, night sweats, fatigue, and substantial weight loss, which can lead to progressive loss of lung volume and respiratory failure if left unmanaged.
- cdc.gov
Chronic pulmonary histoplasmosis is a persistent, progressive fungal infection of the respiratory system caused by the inhalation of *Histoplasma capsulatum* spores
- nih.gov
Chronic pulmonary histoplasmosis is a persistent, progressive fungal infection of the respiratory system caused by the inhalation of *Histoplasma capsulatum* spores Clinically, affected patients experience an insidious, prolonged illness characterized by chronic productive cough, hemoptysis, dyspnea, low-grade fevers, night sweats, fatigue, and substantial weight loss, which can lead to progressive loss of lung volume and respiratory failure if left unmanaged
- nih.gov
This clinical entity predominantly affects older adults and individuals with pre-existing structural lung diseases, particularly emphysema or chronic obstructive pulmonary disease Pathophysiologically, the organism colonizes abnormal lung spaces, prompting sustained necrotizing inflammation, pulmonary fibrosis, and progressive apical or upper-lobe cavitation that closely mimics pulmonary tuberculosis Clinically, affected patients experience an insidious, prolonged illness characterized by chroni...
- clevelandclinic.org
This clinical entity predominantly affects older adults and individuals with pre-existing structural lung diseases, particularly emphysema or chronic obstructive pulmonary disease
- nih.gov
Pathophysiologically, the organism colonizes abnormal lung spaces, prompting sustained necrotizing inflammation, pulmonary fibrosis, and progressive apical or upper-lobe cavitation that closely mimics pulmonary tuberculosis
- creative-biolabs.com
Pathophysiologically, the organism colonizes abnormal lung spaces, prompting sustained necrotizing inflammation, pulmonary fibrosis, and progressive apical or upper-lobe cavitation that closely mimics pulmonary tuberculosis Clinically, affected patients experience an insidious, prolonged illness characterized by chronic productive cough, hemoptysis, dyspnea, low-grade fevers, night sweats, fatigue, and substantial weight loss, which can lead to progressive loss of lung volume and respiratory fai...
Personalize your experience
Follow Chronic pulmonary histoplasmosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.